Another potential therapeutic target for cancer treatment is represented by cyclin B1, the regulatory subunit of cyclin-dependent kinase 1 (cdk1), which plays a pivotal role in the transition of the cell cycle from G2 phase to mitosis [18]. The gene discussed is CCNB1; the disease is cancer.